Cervical squamous cell carcinoma. Robboy's Pathology of the Female Reproductive Tract, pp.227-247, 2009. ,
Cancer incidence and mortality in Europe, Annals of Oncology, pp.481-488, 2004. ,
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication, Int J Cancer, vol.128, pp.927-935, 2011. ,
Cervical Cancer Staging: A Resident's Primer: Women's Imaging. RadioGraphics, pp.933-934, 2016. ,
Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study, J Clin Oncol, vol.24, pp.5687-5694, 2006. ,
Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology, Eur Radiol, vol.29, pp.792-805, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02420660
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database of Systematic Reviews, 2015. ,
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis, Lancet, vol.358, pp.781-786, 2001. ,
The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer, Gynecol Oncol, vol.107, pp.122-126, 2007. ,
Cervical cancer: serial MR imaging before and after primary radiation therapy-a 2-year follow-up study. Radiology. 1992, pp.89-93 ,
Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results, Cancer, vol.113, pp.2158-2165, 2008. ,
Value of diffusion-weighted MRI in diagnosis of uterine cervical cancer: a prospective study evaluating the benefits of DWI compared to conventional MR sequences in a 3T environment, Acta Radiologica, pp.869-877, 2016. ,
Cervical cancer: MR imaging findings before, during, and after radiation therapy, pp.313-324, 2006. ,
Neoadjuvant chemotherapy in ovarian, primary peritoneal and tubal carcinoma: can imaging results prior to interval debulking predict survival?, J Gynecol Oncol, vol.22, pp.183-187, 2011. ,
Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging, Radiology, vol.204, pp.55-63, 1997. ,
Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study, pp.432-442, 2017. ,
Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy, Radiology, vol.216, pp.803-809, 2000. ,
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer, Radiother Oncol, vol.127, pp.404-416, 2018. ,
Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study, Int J Clin Oncol, 2019. ,
Meta-analysis showing that early response to neoadjuvant chemotherapy predicts better survival among cervical cancer patients, Oncotarget, vol.8, pp.59609-59617, 2017. ,
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database of Systematic Reviews, 2015. ,
Impact of pelvic MRI in routine clinical practice on staging of IB1-IIA2 cervical cancer, Cancer Manag Res, vol.11, pp.3603-3609, 2019. ,
Repeatability and reproducibility of MRI-based radiomic features in cervical cancer, Radiother Oncol, vol.135, pp.107-114, 2019. ,
Preoperative prediction of pelvic lymph nodes metastasis in early-stage cervical cancer using radiomics nomogram developed based on T2-weighted MRI and diffusion-weighted imaging, Eur J Radiol, vol.114, pp.128-135, 2019. ,
MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls, Abdom Radiol (NY), vol.44, pp.2557-2571, 2019. ,
Value of diffusionweighted MRI in diagnosis of uterine cervical cancer: a prospective study evaluating the benefits of DWI compared to conventional MR sequences in a 3T environment, Acta Radiologica, pp.869-877, 2016. ,
Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study, Radiology, vol.284, pp.432-442, 2017. ,
Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions, AJR Am J Roentgenol, vol.166, pp.401-408, 1996. ,
Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy, Radiology, vol.216, pp.803-809, 2000. ,
Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging, Radiology, vol.204, pp.55-63, 1997. ,
Functional imaging of colorectal cancer angiogenesis, Lancet Oncol, vol.8, pp.245-255, 2007. ,
Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer, European Radiology, pp.1104-1113, 2019. ,
Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results, AJR Am J Roentgenol, vol.191, pp.1331-1338, 2008. ,
Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications, Gynecol Oncol, vol.99, pp.166-70, 2005. ,
Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer), Gynecol Oncol, vol.102, pp.523-529, 2006. ,
Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma, Ann Surg Oncol, vol.12, pp.332-337, 2005. ,
Faculty of 1000 evaluation for Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer. F1000 -Post-publication peer review of the biomedical literature, 2012. ,
Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma, Eur J Surg Oncol, vol.33, pp.498-503, 2007. ,
Cervical cancer: serial MR imaging before and after primary radiation therapy--a 2-year follow-up study. Radiology. 1992, pp.89-93 ,
Diffusionweighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations, Neoplasia, vol.11, pp.102-125, 2009. ,
Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?, Radiology, vol.211, pp.101-110, 1999. ,
Characterization of complex adnexal masses: value of adding perfusion-and diffusionweighted MR imaging to conventional MR imaging, Radiology, vol.258, pp.793-803, 2011. ,
Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging, Int J Radiat Oncol Biol Phys, vol.45, pp.639-644, 1999. ,